ReviewTherapeutic advances in urology

iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia.

Dhivya Balakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.